LOMUSTINE CAPSULE 40MG
| Generic Name | Lomustine |
| Strength | 40 mg |
| Dosage Form | Capsule |
| Route of Administration | Oral |
| Therapeutic Class | Anticancer/Nitrosourea Alkylating Agent |
| Indications | Brain tumors, Hodgkin’s lymphoma |
| Prescription Required | Yes |
| Administration | Single oral dose at intervals as prescribed |
| Storage | Store below 25°C and protect from moisture and light |
| Manufacturer | As per the pack details |
LOMUSTINE CAPSULE 40MG
Lomustine Capsule 40mg is a prescription oral chemotherapy medicine from the nitrosourea class of alkylating agents. It is widely used in the treatment of primary and metastatic brain tumors and is also prescribed for Hodgkin’s lymphoma as part of combination cancer therapy. This medication is trusted in oncology for its ability to target aggressive tumor cells.
Lomustine 40 mg Capsule works by damaging the DNA and RNA of cancer cells, preventing them from growing and multiplying. Disrupting the cellular structure of malignant cells, it helps slow tumor progression and enhances the effectiveness of multi-drug chemotherapy regimens when used under professional medical care.
Taken orally at carefully scheduled intervals, Lomustine 40 mg Capsule is administered under strict oncologist supervision to ensure safe and effective treatment. The dosing plan is customized according to the patient’s condition, supporting long-term cancer management while minimizing risks and side effects.
Product Features
- Nitrosourea alkylating agent chemotherapy
- Used in brain tumors and Hodgkin’s lymphoma
- Crosses the blood–brain barrier effectively
- Oral capsule with an intermittent dosing schedule
- Long-acting anticancer activity
- Prescription-only oncology medication
How It Helps
- Damages cancer cell DNA and RNA to stop tumor growth
- Effectively treats primary and metastatic brain tumors
- Crosses the blood–brain barrier to target brain cancer cells
- Supports the treatment of Hodgkin’s lymphoma in combination therapy

Reviews
There are no reviews yet.